Table 1:
Characteristics of subjects with vaginal Candida compared with those without vaginal Candida.
| Characteristics | Total Cohort | Candida Positive | Candida Negative | P-value |
|---|---|---|---|---|
| Total Number of Subjects | 255 | 42 (16.5) | 213 (83.5) | |
| Age | 0.811 | |||
| < 20 | 28 (11.0) | 6 (14.3) | 22 (10.3) | |
| 20 to 29 | 178 (69.8) | 29 (69.0) | 149 (70.0) | |
| 30 to 39 | 44 (17.3) | 7 (16.7) | 37 (17.4) | |
| 40 + | 5 (2.0) | 0 (0.0) | 5 (2.3) | |
| Race | 0.042 | |||
| Black | 120 (47.1) | 26 (61.9) | 94 (44.1) | |
| White | 135 (52.9) | 16 (38.1) | 119 (55.9) | |
| Nugent-defined Vaginal Flora | 0.833 | |||
| Normal | 102 (40.0) | 15 (35.7) | 87 (40.8) | |
| Intermediate | 109 (42.7) | 19 (45.2) | 90 (42.3) | |
| BV | 44 (17.3) | 8 (19.0) | 36 (16.9) | |
| Socioeconomic Status (SES) | 1 | |||
| Low SES | 138 (54.1) | 23 (54.8) | 115 (54.0) | |
| Not Low SES | 117 (45.9) | 19 (45.2) | 98 (46.0) | |
| Body Mass Index (kg/m2) | 0.127 | |||
| Underweight (< 18.5) | 15 (5.9) | 3 (7.1) | 12 (5.6) | |
| Normal Weight (18.5 – 24.9) | 103 (40.4) | 19 (45.2) | 84 (39.4) | |
| Overweight (25 – 30) | 48 (18.8) | 11 (26.2) | 37 (17.4) | |
| Obese (> 30) | 78 (30.6) | 7 (16.7) | 71 (33.3) | |
| Not Documented | 11 (4.3) | 2 (4.8) | 9 (4.2) | |
| Current Birth Control Method | 0.320 | |||
| Estrogen + Progestina | 72 (28.2) | 16 (38.1) | 56 (26.3) | |
| Progestinb | 12 (4.7) | 1(2.4) | 11 (5.2) | |
| Non-Hormonalc | 171 (67.1) | 25 (59.5) | 146 (68.5) | |
| Vaginal Douching in Last 180 Days | 0.323 | |||
| Yes | 72 (28.2) | 8 (19.0) | 64 (30.0) | |
| No | 182 (71.4) | 34 (81.0) | 148 (69.5) | |
| Don’t Know | 1 (0.4) | 0 (0.0) | 1 (0.5) | |
| Gravidity | 0.160 | |||
| None | 91 (35.7) | 15 (35.7) | 76 (35.7) | |
| 1 | 58 (22.7) | 6 (14.3) | 52 (24.4) | |
| 2 | 47 (18.4) | 6 (14.3) | 41 (19.2) | |
| 3+ | 59 (23.1) | 15 (35.7) | 44 (20.7) | |
| Community Type | 0.113 | |||
| L. crispatus-dominant | 52 (20.4) | 5 (11.9) | 47 (22.1) | |
| L. iners-dominant | 99 (38.8) | 23 (54.8) | 76 (35.7) | |
| L. jensenii-dominant | 3 (1.2) | 1 (2.4) | 2 (0.9) | |
| L. gasseri-dominant | 3 (1.2) | 0 (0.0) | 3 (1.4) | |
| Diverse | 98 (38.4) | 13 (31.0) | 85 (39.9) |
Values are n (%). Fisher’s Exact Tests were used to determine p-values for each set of variables without adjusting for race. Note that p-values given in the text use GLM (accounting for race as a potential confounder).
a
Women who reported the oral contraceptive pill or the birth control ring;
b
Women who reported the levonorgestrel-containing intrauterine device or depot medroxyprogesterone acetate;
c
Women who reported condoms, rhythm/natural family planning, abstinence, withdrawal or nothing.